查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1617120

2030 年研究抗体和试剂市场预测：按技术、应用、最终用户和地区进行的全球分析

Research Antibodies and Reagents Market Forecasts to 2030 - Global Analysis By Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2024 年全球研究抗体和试剂市场规模为 128.3 亿美元，预计到 2030 年将达到 211.6 亿美元，在预测期内复合年增长率为 8.7%。

研究抗体和试剂是科学实验的重要工具，主要是在分子生物学、免疫学和生物化学领域。抗体是由免疫系统产生的蛋白质，专门设计用于与特异性抗原结合，对于检测、识别和定量各种生物样本中的蛋白质和其他分子非常有用。另一方面，研究试剂是指促进或增强实验过程的各种物质，例如缓衝液、酵素、引子和实验中使用的其他化学物质。这些试剂透过提供反应所需的化学环境和生物成分，帮助优化实验的准确性和可靠性。

根据 CBRE Research 的数据，过去 5 年美国生命科学公司的研发支出增加了 40%，到 2021 年将达到近 1,540 亿美元。

个人化医疗需求不断成长

个人化医疗根据个人的遗传、生活方式和特定疾病特征量身订做治疗方案，需要准确且有针对性的诊断工具。研究性抗体对于检测特定蛋白质和生物标记至关重要，以及支持各种实验程序的试剂在个人化治疗的进步中发挥重要作用。这些抗体和试剂用于基因检测、生物标记发现和药物开发，这些都是个人化医疗的基本要素。在分子层面上准确理解疾病机制的能力对于开发更有效且副作用更少的治疗方法极为重要。

产品高成本

研究抗体和试剂的高成本是科学进步的主要障碍，特别是在免疫学、生物技术和药物开发等领域。由于产量有限、品管标准和原材料成本等因素，这些用于诊断、蛋白质分析和细胞研究等实验的基本工具往往价格昂贵得令人望而却步。许多学术机构、小型实验室和崭露头角的研究人员面临预算限制，难以获得所需的抗体和试剂。其结果是计划延迟、实验范围有限、科学进展缓慢。

增加对癌症研究的投资

对癌症研究的投资增加正在推动研究抗体和试剂的开发取得重大进展，这些抗体和试剂是在分子层面上理解和靶向癌症的重要工具。随着癌症研究的不断发展，资金正在帮助科学家开发更特异性、更敏感和更多样化的抗体，提高我们检测癌症标记和追踪肿瘤进展的能力。这些试剂在基础研究和临床实践中都很重要，有助于更深入地了解癌症生物学、确定新的治疗标靶并改进诊断方法。人们对免疫疗法和个人化医疗的日益关注进一步增加了对高品质抗体的需求，这些抗体可以靶向特定癌细胞，同时最大限度地减少对健康组织的损害。

品质和特异性问题

研究抗体和试剂市场面临与品质和特异性问题相关的重大挑战，阻碍了其科学研究的有效性。抗体对于蛋白质检测和分析至关重要，但由于製造过程的变化和验证不足，抗体的性能常常不一致。因此，重现性可能很差，且抗体可能与非预期目标结合，导致结果不准确。缺乏标准化的试剂配方可能会使实验方案变得复杂，并使研究人员难以在不同实验室之间重现结果。

COVID-19 的影响：

COVID-19 大流行对研究抗体和试剂市场产生了重大影响，扰乱了供应链、研究重点和製造流程。在疫情最严重时期，随着许多实验室和研究机构将重点转向研究该病毒，对专门用于检测和治疗 COVID-19 的抗体、试剂和诊断工具的需求增加。这迫使许多研究人员透过购买替代试剂和改变研究通讯协定来适应。儘管有这些挑战，大流行加速了抗体和试剂开发的创新，特别是在病毒检测和疫苗研究方面。

流式细胞技术领域预计将成为预测期内最大的细分市场

预计流式细胞技术领域在预测期内将占据最大份额。流式细胞技术是免疫学、细胞生物学和诊断学中的强大工具，可根据细胞的物理和化学特性对细胞进行分析和分类。增强研究抗体和试剂对于提高流式细胞技术技术的准确性和可靠性至关重要。透过开发高度特异性和优化的抗体，研究人员可以靶向多种细胞表面标誌物和细胞内蛋白质，从而促进复杂生物过程的研究。萤光偶联物、缓衝液和检测系统等试剂创新将进一步提高流式细胞技术的灵敏度、解析度和准确性。

预计药物开发领域在预测期内复合年增长率最高。

预计药物开发领域将在预测期内快速成长。药物开发领域越来越注重增强研究抗体和试剂，以加速新疗法的发现和开发。这些抗体和试剂在阐明疾病的潜在机制、识别潜在的药物标靶和检验候选治疗药物方面发挥重要作用。提高这些工具的品质、特异性和可靠性将使研究人员能够产生更准确和可重复的资料，这对于推进药物发现至关重要。研究抗体的富集对于准确的生物标记检测、细胞讯号路径分析和体外诊断应用非常有用。

比最大的地区

预计北美地区将在整个预测期内占据最大的市场份额。随着生物技术、製药和个人化医疗的不断进步，对高品质抗体和试剂的需求正在迅速增加。这些工具对于标靶治疗、生物标记识别和诊断的开发至关重要，特别是在癌症、自体免疫疾病和感染疾病。北美研究人员正在利用 CRISPR 和基因编辑等尖端技术，这些技术在很大程度上依赖专门的试剂和抗体。此外，製药公司和学术机构加大研发投资也进一步加速了该地区的需求。

复合年增长率最高的地区：

据估计，欧洲地区在预测期内的复合年增长率最高。透过促进学术机构、研究机构和生物技术公司之间的合作，欧洲已成为生命科学前沿发展的中心。这些伙伴关係能够共用专业知识、资源和技术，以加速高品质抗体和试剂的发现和优化。此外，与全球产业领导者的合资企业和合作确保获得最新技术和监管见解，促进更具体、更有效的研究工具的开发。因此，欧洲研究人员受益于更广泛的专业产品，提高了他们进行准确和有影响力的实验的能力。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和复合年增长率（註：基于可行性检查）
  • 竞争标基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 司机
  • 抑制因素
  • 机会
  • 威胁
  • 技术分析
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • COVID-19 的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球研究抗体与试剂市场：依技术分类

  • 流式细胞技术
  • 免疫沉淀分析法
  • 蛋白质印迹法
  • 多重免疫吸附测定
  • 酵素免疫分析法
  • 其他技术

第六章 全球研究抗体与试剂市场：依应用分类

  • 药物开发
  • 蛋白质体学
  • 基因组学

第七章 全球研究抗体与试剂市场：依最终使用者分类

  • 製药和生物技术产业
  • 学术研究所
  • 合约研究组织

第八章全球研究抗体和试剂市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第九章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务拓展
  • 其他关键策略

第 10 章 公司概况

  • Abcam Limited
  • Agilent Technologies, Inc
  • Bio-Rad Laboratories, Inc
  • F. Hoffmann-La Roche AG
  • GE Healthcare Life Sciences
  • Merck Group
  • OriGene Technologies
  • PerkinElmer
  • Promega Corporation
  • SAB Biotherapeutics
  • Santa Cruz Biotechnology
  • Tecan Group
  • Thermo Fisher Scientific
  • Eppendorf AG
  • Lonza Group
Product Code: SMRC27998

According to Stratistics MRC, the Global Research Antibodies and Reagents Market is accounted for $12.83 billion in 2024 and is expected to reach $21.16 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Research antibodies and reagents are essential tools in scientific experiments, primarily in the fields of molecular biology, immunology, and biochemistry. Antibodies, which are proteins produced by the immune system, are specifically designed to bind to unique antigens, making them invaluable for detecting, identifying, and quantifying proteins or other molecules in various biological samples. Research reagents, on the other hand, refer to a broad range of substances that facilitate or enhance laboratory procedures, including buffers, enzymes, primers, and other chemicals used in experiments. These reagents help optimize the accuracy and reliability of experiments by providing the necessary chemical environment or biological components for reactions to occur.

According to CBRE Research, R&D expenditures by US life sciences companies have grown by ~ 40% over the past five years to reach nearly USD 154 billion in 2021.

Market Dynamics:

Driver:

Rising demand for personalized medicine

Personalized medicine, which tailors treatments based on an individual's genetic makeup, lifestyle, and specific disease characteristics, requires precise and targeted diagnostic tools. Research antibodies, which are essential for detecting specific proteins or biomarkers, and reagents that enable various laboratory procedures, play a crucial role in advancing personalized therapies. These antibodies and reagents are utilized in the development of genetic testing, biomarker discovery, and drug development, which are integral components of personalized medicine. The ability to accurately target disease mechanisms at a molecular level is pivotal in developing treatments that are more effective and have fewer side effects.

Restraint:

High cost of products

The high cost of research antibodies and reagents is a significant barrier to scientific progress, particularly in fields like immunology, biotechnology, and drug development. These essential tools, used for experiments such as diagnostics, protein analysis, and cell research, are often prohibitively expensive due to factors like limited production, high-quality control standards, and the cost of raw materials. Many academic institutions, small labs, and emerging researchers face budget constraints, making it difficult to access the required antibodies and reagents. This results in delayed projects, limited scope of experiments, and a slowdown in scientific advancements.

Opportunity:

Increased investment in cancer research

Increased investment in cancer research is driving significant advancements in the development of research antibodies and reagents, which are essential tools for understanding and targeting cancer at the molecular level. As cancer research continues to evolve, funding has allowed scientists to develop more specific, sensitive, and diverse antibodies, enhancing their ability to detect cancer markers and track tumor progression. These reagents are critical in both basic research and clinical settings, facilitating a deeper understanding of cancer biology, identifying new therapeutic targets, and improving diagnostics. The growing focus on immunotherapy and personalized medicine has further fueled the demand for high-quality antibodies, which can target specific cancer cells while minimizing damage to healthy tissue.

Threat:

Quality and specificity issues

The research antibodies and reagents market is facing significant challenges related to quality and specificity issues, which are hampering their effectiveness in scientific studies. Antibodies, crucial for detecting and analyzing proteins, often suffer from inconsistency in performance due to variations in manufacturing processes and inadequate validation. This results in poor reproducibility, where antibodies may bind to unintended targets, leading to inaccurate results. The lack of standardization in reagent formulations complicates experimental protocols, as researchers may face difficulty replicating results across different laboratories.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the research antibodies and reagents market, disrupting supply chains, research priorities, and manufacturing processes. During the height of the pandemic, many laboratories and research institutions shifted focus toward studying the virus, which led to an increased demand for antibodies, reagents, and diagnostic tools specific to COVID-19 detection and treatment. This situation forced many researchers to adapt by sourcing alternative reagents or modifying their research protocols. Despite these challenges, the pandemic also accelerated innovations in antibody and reagent development, especially for virus detection and vaccine research, which will likely have lasting benefits for future immunological studies and diagnostics.

The Flow Cytometry segment is expected to be the largest during the forecast period

Flow Cytometry segment is expected to dominate the largest share over the estimated period. Flow cytometry is a powerful tool used in immunology, cell biology, and diagnostics to analyze and sort cells based on their physical and chemical properties. The segment focused on enhancing research antibodies and reagents is crucial for improving the precision and reliability of flow cytometry techniques. By developing highly specific and optimized antibodies, researchers can target a wide range of cell surface markers and intracellular proteins, facilitating the study of complex biological processes. Innovations in reagents, such as fluorescence conjugates, buffers, and detection systems, further enhance the sensitivity, resolution, and accuracy of flow cytometry.

The Drug Development segment is expected to have the highest CAGR during the forecast period

Drug Development segment is estimated to grow at a rapid pace during the forecast period. The drug development sector is increasingly focusing on enhancing research antibodies and reagents to accelerate the discovery and development of new therapeutics. These antibodies and reagents play a critical role in understanding the underlying mechanisms of diseases, identifying potential drug targets, and validating therapeutic candidates. By improving the quality, specificity, and reliability of these tools, researchers can generate more accurate and reproducible data, which is essential for advancing drug discovery. Enhanced research antibodies help in precise biomarker detection, cell signaling pathway analysis and in vitro diagnostic applications.

Region with largest share:

North America region is poised to hold the largest share of the market throughout the extrapolated period. With continuous advancements in biotechnology, pharmaceuticals, and personalized medicine, the demand for high-quality antibodies and reagents has surged. These tools are crucial for the development of targeted therapies, biomarker identification, and diagnostics, especially in cancer, autoimmune diseases, and infectious diseases. North American researchers are leveraging cutting-edge techniques such as CRISPR and gene editing, which rely heavily on specialized reagents and antibodies. Additionally, increasing investment in research and development by pharmaceutical companies and academic institutions is further accelerating the demand across the region.

Region with highest CAGR:

Europe region is estimated to witness the highest CAGR during the projected time frame. By fostering collaborations between academic institutions, research organizations, and biotechnology companies, Europe has become a hub for cutting-edge developments in life sciences. These partnerships enable the sharing of expertise, resources, and technologies, which accelerates the discovery and optimization of high-quality antibodies and reagents. Additionally, joint ventures and collaborations with global industry leaders ensure access to the latest technologies and regulatory insights, promoting the development of more specific and effective research tools. As a result, European researchers benefit from a wider array of specialized products, enhancing their ability to conduct precise and impactful experiments.

Key players in the market

Some of the key players in Research Antibodies and Reagents market include Abcam Limited, Agilent Technologies, Inc, Bio-Rad Laboratories, Inc, F. Hoffmann-La Roche AG, GE Healthcare Life Sciences, Merck Group, OriGene Technologies, PerkinElmer, Promega Corporation, SAB Biotherapeutics, Santa Cruz Biotechnology, Tecan Group, Thermo Fisher Scientific, Eppendorf AG and Lonza Group.

Key Developments:

In August 2023, Danaher (US) entered into a definitive agreement to acquire all the outstanding shares of Abcam plc (UK). Through this development, Abcam is expected to operate as a standalone operating company within Danaher's Life Sciences segment.

In August 2023, Agilent Technologies, Inc. (US) announced the opening of a new full-scale Integrated Biology Center located at Monash University in Malaysia. The facility is focused on building local capabilities to accelerate research and development (R&D) in life science research.

Technologies Covered:

  • Flow Cytometry
  • Immunoprecipitation
  • Western Blotting
  • Multiplex Immunosorbent Assay
  • Enzyme-Linked Immunosorbent Assay
  • Other Technologies

Applications Covered:

  • Drug Development
  • Proteomics
  • Genomics

End Users Covered:

  • Pharmaceutical and Biotechnologies Industries
  • Academic and Research Institutions
  • Contract Research Organizations

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Research Antibodies and Reagents Market, By Technology

  • 5.1 Introduction
  • 5.2 Flow Cytometry
  • 5.3 Immunoprecipitation
  • 5.4 Western Blotting
  • 5.5 Multiplex Immunosorbent Assay
  • 5.6 Enzyme-Linked Immunosorbent Assay
  • 5.7 Other Technologies

6 Global Research Antibodies and Reagents Market, By Application

  • 6.1 Introduction
  • 6.2 Drug Development
  • 6.3 Proteomics
  • 6.4 Genomics

7 Global Research Antibodies and Reagents Market, By End User

  • 7.1 Introduction
  • 7.2 Pharmaceutical and Biotechnologies Industries
  • 7.3 Academic and Research Institutions
  • 7.4 Contract Research Organizations

8 Global Research Antibodies and Reagents Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abcam Limited
  • 10.2 Agilent Technologies, Inc
  • 10.3 Bio-Rad Laboratories, Inc
  • 10.4 F. Hoffmann-La Roche AG
  • 10.5 GE Healthcare Life Sciences
  • 10.6 Merck Group
  • 10.7 OriGene Technologies
  • 10.8 PerkinElmer
  • 10.9 Promega Corporation
  • 10.10 SAB Biotherapeutics
  • 10.11 Santa Cruz Biotechnology
  • 10.12 Tecan Group
  • 10.13 Thermo Fisher Scientific
  • 10.14 Eppendorf AG
  • 10.15 Lonza Group

List of Tables

  • Table 1 Global Research Antibodies and Reagents Market Outlook, By Region (2022-2030) ($MN)
  • Table 2 Global Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 3 Global Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 4 Global Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 5 Global Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 6 Global Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 7 Global Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 8 Global Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 9 Global Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 10 Global Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 11 Global Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 12 Global Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 13 Global Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 14 Global Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 15 Global Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 16 Global Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 17 North America Research Antibodies and Reagents Market Outlook, By Country (2022-2030) ($MN)
  • Table 18 North America Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 19 North America Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 20 North America Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 21 North America Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 22 North America Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 23 North America Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 24 North America Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 25 North America Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 26 North America Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 27 North America Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 28 North America Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 29 North America Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 30 North America Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 31 North America Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 32 North America Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 33 Europe Research Antibodies and Reagents Market Outlook, By Country (2022-2030) ($MN)
  • Table 34 Europe Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 35 Europe Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 36 Europe Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 37 Europe Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 38 Europe Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 39 Europe Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 40 Europe Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 41 Europe Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 42 Europe Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 43 Europe Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 44 Europe Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 45 Europe Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 46 Europe Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 47 Europe Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 48 Europe Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 49 Asia Pacific Research Antibodies and Reagents Market Outlook, By Country (2022-2030) ($MN)
  • Table 50 Asia Pacific Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 51 Asia Pacific Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 52 Asia Pacific Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 53 Asia Pacific Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 54 Asia Pacific Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 55 Asia Pacific Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 56 Asia Pacific Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 57 Asia Pacific Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 58 Asia Pacific Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 59 Asia Pacific Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 60 Asia Pacific Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 61 Asia Pacific Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 62 Asia Pacific Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 63 Asia Pacific Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 64 Asia Pacific Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 65 South America Research Antibodies and Reagents Market Outlook, By Country (2022-2030) ($MN)
  • Table 66 South America Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 67 South America Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 68 South America Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 69 South America Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 70 South America Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 71 South America Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 72 South America Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 73 South America Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 74 South America Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 75 South America Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 76 South America Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 77 South America Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 78 South America Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 79 South America Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 80 South America Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)
  • Table 81 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Country (2022-2030) ($MN)
  • Table 82 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Technology (2022-2030) ($MN)
  • Table 83 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Flow Cytometry (2022-2030) ($MN)
  • Table 84 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Immunoprecipitation (2022-2030) ($MN)
  • Table 85 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Western Blotting (2022-2030) ($MN)
  • Table 86 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Multiplex Immunosorbent Assay (2022-2030) ($MN)
  • Table 87 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Enzyme-Linked Immunosorbent Assay (2022-2030) ($MN)
  • Table 88 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Other Technologies (2022-2030) ($MN)
  • Table 89 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Application (2022-2030) ($MN)
  • Table 90 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Drug Development (2022-2030) ($MN)
  • Table 91 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Proteomics (2022-2030) ($MN)
  • Table 92 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Genomics (2022-2030) ($MN)
  • Table 93 Middle East & Africa Research Antibodies and Reagents Market Outlook, By End User (2022-2030) ($MN)
  • Table 94 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Pharmaceutical and Biotechnologies Industries (2022-2030) ($MN)
  • Table 95 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
  • Table 96 Middle East & Africa Research Antibodies and Reagents Market Outlook, By Contract Research Organizations (2022-2030) ($MN)